Latest data from October 8, 2021
Number of Health Center respondents = 31 (72% of all Health Centers)
Data represents information provided by health centers from a single, specified reporting date. Summary information across report dates is not comparable due to differences in which health centers responded for a given report date.
Patients Tested
| Metrics | Value |
|---|---|
| Patients Tested for COVID-19, Virus Detection (PCR, antigen)1 | 9,396 |
| Racial and/or Ethnic Minority Patients Tested for COVID-19, Virus Detection (PCR, antigen) | 45.95% |
| Patients Tested Positive for COVID-19, Virus Detection (PCR, antigen)1 | 994 |
| Racial and/or Ethnic Minority Patients Tested Positive for COVID-19, Virus Detection (PCR, antigen) | 30.33% |
Patients by Race and Ethnicity
| Race/Ethnicity | Patients Tested, Virus Detection (PCR, antigen)2 | Patients Tested Positive, Virus Detection (PCR, antigen)2 |
|---|---|---|
| White, Non-Hispanic/Latino Patients | 47.34% | 63.08% |
| White, Hispanic/Latino Patients | 9.07% | 5.73% |
| Black/African American, Non-Hispanic/Latino Patients | 17.49% | 13.18% |
| Black/African American, Hispanic/Latino Patients | 1.35% | 1.01% |
| Asian Patients3 | 2.69% | 1.71% |
| American Indian/Alaska Native Patients3 | 0.28% | 0.20% |
| Native Hawaiian/Other Pacific Islander Patients3 | 0.30% | 0.10% |
| Patients with More than one race3 | 1.30% | 0.91% |
| Hispanic/Latino Ethnicity Patients (Unreported/Refused to report race) | 7.78% | 4.63% |
| Non-Hispanic/Latino Ethnicity Patients (Unreported/Refused to report race) | 8.84% | 5.73% |
| Unreported/Refused to Report Race and Ethnicity | 3.57% | 3.72% |
Patients Vaccinated
| Metrics | Value |
|---|---|
| COVID-19 Immunization Series Initiated | 1,827 |
| Racial and/or Ethnic Minority Patients Who Initiated COVID-19 Immunization | 73.64% |
| COVID-19 Immunization Series Completed | 1,815 |
| Racial and/or Ethnic Minority Patients Who Completed COVID-19 Immunization | 76.89% |
| COVID-19 Immunization Series Additional | 306 |
| Racial and/or Ethnic Minority Patients Who Received an Additional Dose of COVID-19 Vaccine | 49.80% |
Vaccinations by Race and Ethnicity
| Race/Ethnicity | Patient COVID-19 Immunization Series Initiated2 | Patient COVID-19 Immunization Series Completed2 | Patient COVID-19 Immunization Series Additional2 |
|---|---|---|---|
| White, Non-Hispanic/Latino Patients | 22.88% | 18.73% | 41.50% |
| White, Hispanic/Latino Patients | 13.41% | 18.13% | 7.84% |
| Black/African American, Non-Hispanic/Latino Patients | 28.41% | 22.81% | 16.01% |
| Black/African American, Hispanic/Latino Patients | 2.24% | 1.71% | 1.63% |
| Asian Patients3 | 2.19% | 2.70% | 4.25% |
| American Indian/Alaska Native Patients3 | 0.49% | 0.22% | 4.25% |
| Native Hawaiian/Other Pacific Islander Patients3 | 1.31% | 1.32% | 0.65% |
| Patients with More than one race3 | 3.07% | 2.64% | 3.27% |
| Hispanic/Latino Ethnicity Patients (Unreported/Refused to report race) | 12.81% | 12.78% | 3.27% |
| Non-Hispanic/Latino Ethnicity Patients (Unreported/Refused to report race) | 3.12% | 9.20% | 4.25% |
| Unreported/Refused to Report Race and Ethnicity | 10.07% | 9.75% | 13.07% |
Testing Logistics
Average Turnaround Time for COVID-19 Test Results, Virus Detection (PCR, antigen)
| Metrics | Value |
|---|---|
| Less Than 1 Hour | 12.90% |
| 1 to 24 Hours | 12.90% |
| More Than 24 Hours | 74.19% |
| N/A | 0.00% |
Vaccine Logistics
Challenges in Deploying the COVID Vaccine
| Metrics | Value |
|---|---|
| Financial reimbursement for costs associated with vaccine administration | 12.90% |
| Staffing to administer the vaccine | 35.48% |
| Vaccine confidence | 32.26% |
| Vaccine storage capacity | 9.68% |
| Vaccine supply | 3.23% |
| Other | 9.68% |
| None | 29.03% |
Operations and Staff
| Metrics | Value |
|---|---|
| COVID-19 Vaccine Doses Received Only From Health Center COVID-19 Vaccine Program | 3.23% |
| Average Percent of Health Center Visits Conducted Virtually | 20.97% |
Mobile Vans, Pop-Up Clinics, and School-Based Sites
| Metrics | Value |
|---|---|
| Percent of Health Centers Hosting Mobile Vans, Pop-Up, and/or School-Based Clinics | 58.06% |
| Number of Mobile Van Sites | 21 |
| Number of Pop-up Clinics | 31 |
| Number of School-Based Vaccination Sites | 2 |
Monoclonal Antibody Therapy
Methods in Providing Access to Monoclonal Antibody Therapy
| Metrics | Value |
|---|---|
| Direct provision of monoclonal antibody therapies | 6.45% |
| Refer patients to another organization that provides monoclonal antibody therapies | 48.39% |
| None | 45.16% |
Challenges in Providing Access to Monoclonal Antibody Therapy
| Metrics | Value |
|---|---|
| Access to therapeutics | 12.90% |
| Patient awareness/education | 9.68% |
| Staffing capacity | 22.58% |
| Therapy administration/onsite logistics | 12.90% |
| Other | 9.68% |
| None | 54.84% |
1 The reported number of patients tested do not represent the same patients included in the reported number of patients tested positive due to a lag between the date the specimen is collected and the availability of test results. Positivity rates cannot be inferred by dividing patients tested positive by patients tested for this reason.
2 Percentages may not add to 100% due to rounding to the hundredths.
3 Includes Hispanic/Latino and Non-Hispanic/Latino.
